Immunohistochemistry News and Research

RSS
Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Numira acquires Ricerca' Efficacy Pharmacology operating unit

Numira acquires Ricerca' Efficacy Pharmacology operating unit

TD2 and Flagship Biosciences offer combined oncology and pathology services

TD2 and Flagship Biosciences offer combined oncology and pathology services

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

Study results of Pathwork Diagnostics's Tissue of Origin Test presented at ASCO 2011

OriGene releases 1,500 mouse monoclonal antibodies

OriGene releases 1,500 mouse monoclonal antibodies

Positive results from nimotuzumab Phase II study for gastric cancer

Positive results from nimotuzumab Phase II study for gastric cancer

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

HistoRx grants Metamark worldwide license to AQUA technology for commercialization of Prognostic Assays

HistoRx grants Metamark worldwide license to AQUA technology for commercialization of Prognostic Assays

Genomic Health announces results of Oncotype DX test in early-stage breast cancer patients

Genomic Health announces results of Oncotype DX test in early-stage breast cancer patients

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

IRIS announces product acquisition from BioMicro Systems

IRIS announces product acquisition from BioMicro Systems

NeoGenomics third quarter revenue grows 19% to $8.7 million

NeoGenomics third quarter revenue grows 19% to $8.7 million

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

Combination of MET and erlotinib delays lung cancer progression: Study

Combination of MET and erlotinib delays lung cancer progression: Study